# HuR Knockdown in MLO-Y4 Osteocyte-like Cells Elevates OPG Expression and Suppresses Osteoclastogenesis In Vitro

**Authors:** Ziqiu Fan, Hideki Kitaura, Aseel Marahleh, Abdulrahman Mousa, Fumitoshi Ohori, Alexandru Craevschi, Sherif Rashad, Hiroyasu Kanetaka

PMC · DOI: 10.3390/ijms27010430 · International Journal of Molecular Sciences · 2025-12-31

## TL;DR

This study shows that reducing HuR in osteocyte-like cells increases OPG, which suppresses bone breakdown by osteoclasts.

## Contribution

The study reveals HuR as an indirect regulator of OPG in osteocytes, impacting bone remodeling through post-transcriptional mechanisms.

## Key findings

- HuR knockdown in MLO-Y4 cells significantly increased OPG mRNA and protein without affecting RANKL.
- HuR-deficient osteocytes reduced the osteoclastogenic environment in co-culture and conditioned-medium assays.
- HuR does not directly bind OPG mRNA, suggesting indirect regulation of OPG expression.

## Abstract

Bone remodeling is maintained through the coordinated actions of osteoblasts, osteoclasts, and osteocytes, among which osteocytes serve as major regulators of osteoclast-mediated bone resorption through the receptor activator of the nuclear factor-κB ligand (RANKL)–osteoprotegerin (OPG) signaling axis. While molecular signals regulating osteocytic RANKL-OPG expression are fairly understood, how post-transcriptional mechanisms impact osteocyte function remains poorly defined. HuR (human antigen R) encoded by Elavl1 (embryonic lethal abnormal vision-like 1), a ubiquitously expressed RNA-binding protein, is known for stabilizing AU-rich element-containing transcripts involved in inflammatory and stress responses; however, its role in osteocyte-derived bone resorption is unknown. In this study, we examined the effect of HuR loss on osteocyte–osteoclastogenesis. Short hairpin RNA (shRNA)-mediated HuR knockdown in MLO-Y4 osteocyte-like cells resulted in a significant increase in OPG mRNA and its protein expression, whereas RANKL levels remained unchanged, leading to a significantly reduced RANKL/OPG ratio. Both co-culture and conditioned-medium assays demonstrated that HuR-deficient osteocytes produced a markedly diminished osteoclastogenic environment. Actinomycin D chase experiments showed no alteration in OPG mRNA decay kinetics, and RNA immunoprecipitation (RIP)-PCR failed to detect HuR–OPG interactions, indicating that HuR regulates OPG expression through indirect mechanisms rather than mRNA binding. These findings identify HuR as an indirect regulator of osteocyte-derived OPG expression that impacts osteoclast differentiation and reveal a previously unrecognized mechanism by which HuR contributes to bone remodeling.

## Linked entities

- **Genes:** ELAVL1 (ELAV like RNA binding protein 1) [NCBI Gene 1994], ELAVL1 (ELAV like RNA binding protein 1) [NCBI Gene 1994]
- **Proteins:** ELAVL1 (ELAV like RNA binding protein 1), TNFSF11 (TNF superfamily member 11), BTF3P11 (basic transcription factor 3 pseudogene 11)
- **Chemicals:** Actinomycin D (PubChem CID 457193)

## Full-text entities

- **Genes:** Tnfsf11 (tumor necrosis factor (ligand) superfamily, member 11) [NCBI Gene 21943] {aka Ly109l, ODF, OPGL, RANKL, Trance}, Tnfrsf11b (tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)) [NCBI Gene 18383] {aka OCIF, Opg, TR1}, Elavl1 (ELAV like RNA binding protein 1) [NCBI Gene 15568] {aka 2410055N02Rik, HUR, Hua}
- **Diseases:** inflammatory (MESH:D007249)
- **Chemicals:** Actinomycin D (MESH:D003609)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12786973/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12786973/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12786973/full.md

---
Source: https://tomesphere.com/paper/PMC12786973